# Asia Genomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/asia-genomics

- Industry: Biotechnology
- Headquarters: Singapore
- Website: www.asia-genomics.com
- Total disclosed funding: $8.4M
- Latest round: Series B (Dec 12, 2019)
- Investors on record: 4

## About

Based in Singapore, and founded in 2014 by its CEO Mun-Yew Wong, Asia Genomics Pte. Ltd. operates as a molecular diagnostics company specializing in clinical genomics and genetic testing. The company focuses on implementing genomic technologies with diagnostic laboratories to connect healthcare professionals with genetic tests, enabling clients to integrate scientific approaches with medical and technology partners.

Asia Genomics arranges for all aspects of testing including swabbing, collection/courier,  lab analysis, onsite pre-event antigen rapid test (ART) swabbing, polymerase chain reaction (PCR) testing, routine employee COVID-19 testing, pre-departure COVID-19 testing, clinical diagnostics, clinical screening, sequencing, genomics, cancer genetic tests, somatic cancer, hereditary cancer, liquid biopsy, NIPT, non-invasive prenatal test, genetic test, and solid biopsy.

## Funding rounds

- Series B, Dec 12, 2019, $3M — Raffles Venture Partners, Franklin Capital Group, Ericsenz Capital
- Seed, Oct 21, 2014, $5.4M — Raffles Venture Partners, Formation8

## Investors

- Raffles Venture Partners (https://capitalatlas.ai/funds/raffles-venture-partners) — Seed, Series B
- Formation8 (https://capitalatlas.ai/funds/formation8) — Seed
- Franklin Capital Group — Series B
- Ericsenz Capital (https://capitalatlas.ai/funds/ericsenz-capital) — Series B